| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |